Botulinum Toxin A & Weekly Serial Casting in ABI Inpatients With Lower Extremity Spasticity — ChemoCast

Spastic Foot Clinical Trial

Official title:
Effects of Chemodenervation (Botulinum Toxin A) and Serial Casting vs Botulinum Toxin A and Without Serial Casting in Lower Limb Spasticity Following ABI

Status Withdrawn

Clinical Trial Summary

Effects of Chemodenervation (Botulinum Toxin A) and Serial Casting vs Botulinum Toxin A and without serial casting in Lower Limb Spasticity following ABI.

Clinical Trial Description

The investigators will be studying the effects of Chemodenervation (Botulinum Toxin A) and Serial Casting vs Botulinum Toxin A and without serial casting in Lower Limb Spasticity following ABI. patients are randomly divided into two groups: group 1 will undergo botox injection with weekly serial casting group 2 will undergo botox injection with physiotherapy The primary outcome is the effects of the proposed treatment with respect to passive dorsiflexion. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03903653
Study type	Interventional
Source	Hamilton Health Sciences Corporation
Contact
Status	Withdrawn
Phase	Phase 2
Start date	September 1, 2019
Completion date	December 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05874154` - Evaluation of Tibial Nerve Selective Neurotomy Compared to Botulinum Toxin Injections for Spastic Foot Treatment in Post-stroke Patients According to a Goal-centered Approach	N/A
Recruiting	`NCT05097482` - Triceps Surae Ultrasonographic Characteristics in Hemiparetic Stroke Survivors
Not yet recruiting	`NCT06138418` - Spasticity Multidisciplinary Management : QoL and Physical Activity Measurement With Connected Health Devices (PEPS)	N/A
Completed	`NCT01265238` - Neuro-orthopaedic Surgery in the Treatment of the Spastic Equinovarus Foot	N/A